{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:53:15Z","timestamp":1785538395460,"version":"3.56.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109248","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:22:12Z","timestamp":1763346132000},"page":"109248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recent advances in bioisosteric modifications for targeting Alzheimer's disease pathways"],"prefix":"10.1016","volume":"167","author":[{"given":"Akash","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digambar Kumar","family":"Waiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem Shanker","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushant Kumar","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109248_bb0005","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.3390\/molecules28248038","article-title":"The bioavailability of drugs\u2014the current state of knowledge","volume":"28","author":"Stielow","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109248_bb0010","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/cr950066q","article-title":"Bioisosterism: a rational approach in drug design","volume":"96","author":"Patani","year":"1996","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.109248_bb0015","series-title":"Ligand-based drug design (LBDD)","first-page":"57","author":"Yadav","year":"2022"},{"key":"10.1016\/j.bioorg.2025.109248_bb0020","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/17460441.2021.1933427","article-title":"Applications of fluorine to the construction of bioisosteric elements for the purposes of novel drug discovery","volume":"16","author":"Richardson","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109248_bb0025","first-page":"1","article-title":"The use of bioisosterism in drug design and molecular modification","volume":"2","author":"Gaikwad","year":"2012","journal-title":"Am. J. PharmTech Res"},{"key":"10.1016\/j.bioorg.2025.109248_bb0030","first-page":"317","article-title":"The origins and evolution of the isoelectronic principle","volume":"8","author":"Jensen","year":"2016","journal-title":"Int. J. Chem. Model."},{"key":"10.1016\/j.bioorg.2025.109248_bb0035","series-title":"Bioisosteres in Medicinal Chemistry","author":"Mannhold","year":"2012"},{"key":"10.1016\/j.bioorg.2025.109248_bb0040","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1021\/acs.jmedchem.5c00348","article-title":"Fluorescent Isostere (Fluostere) of the carboxylate: design of h DHODH fluorescent inhibitors as proof of concept","volume":"68","author":"Sainas","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0045","series-title":"Tactics in Contemporary Drug Design","first-page":"283","article-title":"The influence of bioisosteres in drug design: Tactical applications to address developability problems","author":"Meanwell","year":"2014"},{"key":"10.1016\/j.bioorg.2025.109248_bb0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2174\/1573406418666220127124228","article-title":"Bioisosterism in drug discovery and development-an overview","volume":"18","author":"Jayashree","year":"2022","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0055","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in Alzheimer\u2019s disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109248_bb0060","series-title":"World Alzheimer Report 2020: Design, Dignity, Dementia: Dementia-Related Design and the Built Environment","author":"Zeisel","year":"2020"},{"key":"10.1016\/j.bioorg.2025.109248_bb0065","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.1989.03430180093036","article-title":"Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported","volume":"262","author":"Evans","year":"1989","journal-title":"Jama"},{"key":"10.1016\/j.bioorg.2025.109248_bb0070","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.arcmed.2012.11.003","article-title":"Epidemiology of dementias and Alzheimer\u2019s disease","volume":"43","author":"Sosa-Ortiz","year":"2012","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.bioorg.2025.109248_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131152","article-title":"Design, synthesis, and evaluation of some novel biphenyl imidazole derivatives for the treatment of Alzheimer\u2019s disease","volume":"1246","author":"Ramrao","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109248_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105562","article-title":"The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer\u2019s disease","volume":"119","author":"Verma","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0085","first-page":"1","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10.1016\/j.bioorg.2025.109248_bb0090","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2021-7-3","article-title":"Aducanumab: evidence from clinical trial data and controversies","volume":"10","author":"Tampi","year":"2021","journal-title":"Drugs in Context"},{"key":"10.1016\/j.bioorg.2025.109248_bb0095","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","article-title":"Review on Alzheimer\u2019s disease: inhibition of amyloid beta and tau tangle formation","volume":"167","author":"Ashrafian","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.109248_bb0100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3233\/ADR-200237","article-title":"Porphyromonas gingivalis as a risk factor to Alzheimer\u2019s disease: a systematic review","volume":"5","author":"Elwishahy","year":"2021","journal-title":"J. Alzheimer\u2019s Dis. Reports"},{"key":"10.1016\/j.bioorg.2025.109248_bb0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer's disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomedical reports"},{"key":"10.1016\/j.bioorg.2025.109248_bb0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fnmol.2017.00339","article-title":"Biometal dyshomeostasis and toxic metal accumulations in the development of Alzheimer\u2019s disease","volume":"10","author":"Li","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0120","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer\u2019s disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.109248_bb0125","series-title":"The role of CREB signaling in Alzheimer\u2019s disease and other cognitive disorders","article-title":"J. Valero","author":"Saura","year":"2011"},{"key":"10.1016\/j.bioorg.2025.109248_bb0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.26599\/BSA.2018.2018.9050009","article-title":"How could N-methyl-D-aspartate receptor antagonists lead to excitation instead of inhibition?","volume":"4","author":"Su","year":"2018","journal-title":"Brain Sci. Adv."},{"key":"10.1016\/j.bioorg.2025.109248_bb0135","article-title":"The state of the art on acetylcholinesterase inhibitors in the treatment of Alzheimer\u2019s disease","volume":"13","author":"Vecchio","year":"2021","journal-title":"J. Central Nervous Syst. Dis."},{"key":"10.1016\/j.bioorg.2025.109248_bb0140","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.3390\/ijms22179290","article-title":"Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis","volume":"22","author":"Walczak-Nowicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0145","first-page":"187","article-title":"Cholinesterase inhibitors and beyond","volume":"2","author":"Pepeu","year":"2014","journal-title":"Adv. Alzheimer's Res."},{"key":"10.1016\/j.bioorg.2025.109248_bb0150","first-page":"1","article-title":"A review of the cholinergic system and therapeutic approaches to treat brain disorders","author":"Bertrand","year":"2020","journal-title":"Behav. Pharmacol. Cholinergic Syst."},{"key":"10.1016\/j.bioorg.2025.109248_bb0155","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/molecules22101692","article-title":"\u0392-Amyloid and the pathomechanisms of Alzheimer\u2019s disease: a comprehensive view","volume":"22","author":"Penke","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109248_bb0160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2174\/1871527318666191011145941","article-title":"The Structure and Function of \u03b1, \u03b2 and \u03b3-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer\u2019s Disease: A Review","volume":"18","author":"Ahmad","year":"2019","journal-title":"CNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders"},{"key":"10.1016\/j.bioorg.2025.109248_bb0165","series-title":"Regulation of Alzheimer Pathology by Amyloid Seeds: From Toxic Effects to Therapeutic Opportunities, in Mouse Model of Amyloidosis, in","author":"Celestine","year":"2023"},{"key":"10.1016\/j.bioorg.2025.109248_bb0170","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-140933","article-title":"Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer\u2019s disease","volume":"43","author":"Kumar","year":"2014","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.bioorg.2025.109248_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105090","article-title":"Map kinase signaling as therapeutic target for neurodegeneration","volume":"160","author":"Ahmed","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2025.109248_bb0185","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41435-020-00113-5","article-title":"Tau at the interface between neurodegeneration and neuroinflammation","volume":"21","author":"Didonna","year":"2020","journal-title":"Genes Immun."},{"key":"10.1016\/j.bioorg.2025.109248_bb0190","first-page":"285","article-title":"Alzheimer\u2019s disease and protein kinases","author":"Engin","year":"2021","journal-title":"Protein Kinase-Mediated Decisions Between Life and Death"},{"key":"10.1016\/j.bioorg.2025.109248_bb0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1567205014666170417111859","article-title":"Tau in Alzheimer\u2019s disease: mechanisms and therapeutic strategies","volume":"15","author":"Gao","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bioorg.2025.109248_bb0200","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/00207454.2019.1645142","article-title":"Cdk5: a main culprit in neurodegeneration","volume":"129","author":"Gupta","year":"2019","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0205","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/biomedicines9091126","article-title":"Alzheimer\u2019s disease: a molecular view of \u03b2-amyloid induced morbific events","volume":"9","author":"Mohamed Asik","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2025.109248_bb0210","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1007\/s12035-023-03839-1","article-title":"Understanding glycogen synthase kinase-3: a novel avenue for Alzheimer\u2019s disease","volume":"61","author":"Sequeira","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2025.109248_bb0215","first-page":"1","article-title":"An insight into the molecular and therapeutic targets of amyloid plaques in Alzheimer\u2019s disease and an update on the prospects of drugs in research, basic and clinical","volume":"15","author":"Thomas","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.bioorg.2025.109248_bb0220","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1007\/s12035-022-03164-z","article-title":"Role of tau in various tauopathies, treatment approaches, and emerging role of nanotechnology in neurodegenerative disorders","volume":"60","author":"Kaur","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2025.109248_bb0225","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00580-019-02940-z","article-title":"Oxidative stress and stroke: a review of upstream and downstream antioxidant therapeutic options","volume":"28","author":"Komsiiska","year":"2019","journal-title":"Comp. Clin. Pathol."},{"key":"10.1016\/j.bioorg.2025.109248_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/497802","article-title":"Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer\u2019 s disease?","volume":"2014","author":"Luque-Contreras","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bioorg.2025.109248_bb0235","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1007\/s12035-015-9515-5","article-title":"Mechanisms of mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"53","author":"Cadonic","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2025.109248_bb0240","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/1061186X.2019.1584808","article-title":"The role of mitochondrial defects and oxidative stress in Alzheimer\u2019s disease","volume":"27","author":"Islam","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bioorg.2025.109248_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120855","article-title":"Redefining oxidative stress in Alzheimer\u2019s disease: targeting platelet reactive oxygen species for novel therapeutic options","volume":"306","author":"Beura","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0250","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.3390\/ijms19123824","article-title":"The role of NADPH oxidases and oxidative stress in neurodegenerative disorders","volume":"19","author":"Tarafdar","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0255","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.3390\/ijms21207452","article-title":"The dual role of glutamatergic neurotransmission in Alzheimer\u2019s disease: from pathophysiology to pharmacotherapy","volume":"21","author":"Bukke","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0260","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.3390\/molecules29235744","article-title":"Glutamate: molecular mechanisms and signaling pathway in Alzheimer\u2019s disease, a potential therapeutic target","volume":"29","author":"Puranik","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109248_bb0265","series-title":"Natural Product-Based Synthetic Drug Molecules in Alzheimer\u2019s Disease: Therapeutic & Theranostic Agents","first-page":"267","article-title":"Flavonoid-based derivatives for modulating various targets of Alzheimer\u2019s disease","author":"Pandey","year":"2023"},{"key":"10.1016\/j.bioorg.2025.109248_bb0270","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-011-0806-2","article-title":"Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-a\u03b2 deposits in hippocampus via distinct cellular mechanisms","volume":"121","author":"Hartlage-R\u00fcbsamen","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bioorg.2025.109248_bb0275","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/1570159X11311050004","article-title":"Pyroglutamate-modified amyloid beta peptides: emerging targets for Alzheimer s disease immunotherapy","volume":"11","author":"Perez-Garmendia","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bioorg.2025.109248_bb0280","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.3390\/cells11223616","article-title":"Lipid dys-homeostasis contributes to APOE4-associated AD pathology","volume":"11","author":"Lazar","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2025.109248_bb0285","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.3390\/ijms21176336","article-title":"ApoE lipidation as a therapeutic target in Alzheimer\u2019s disease","volume":"21","author":"Lanfranco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0290","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/156720511795745393","article-title":"Simvastatin and other HMG-CoA reductase inhibitors on brain cholesterol levels in Alzheimer\u2019s disease","volume":"8","author":"Longenberger","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bioorg.2025.109248_bb0295","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2174\/1567205016666190823125245","article-title":"ACAT1 as a therapeutic target and its genetic relationship with Alzheimer\u2019s disease","volume":"16","author":"Alavez-Rubio","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bioorg.2025.109248_bb0300","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/jcm9020495","article-title":"The role of periodontitis and periodontal bacteria in the onset and progression of Alzheimer\u2019s disease: a systematic review","volume":"9","author":"Dioguardi","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bioorg.2025.109248_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591571","article-title":"Potential role of phosphoglycerol dihydroceramide produced by periodontal pathogen Porphyromonas gingivalis in the pathogenesis of Alzheimer\u2019s disease","volume":"11","author":"Yamada","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2025.109248_bb0310","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","article-title":"Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease","volume":"1862","author":"Nelson","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.bioorg.2025.109248_bb0315","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3390\/ijms18091965","article-title":"Blood-brain barrier dysfunction and the pathogenesis of Alzheimer\u2019s disease","volume":"18","author":"Yamazaki","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0320","series-title":"Developing novel indanone-chalcone hybrids bearing ester group with potential anti-Alzheimer effects by combining molecular hybridization and bioisosteric replacement drug design approaches","author":"Azimian","year":"2023"},{"key":"10.1016\/j.bioorg.2025.109248_bb0325","doi-asserted-by":"crossref","first-page":"8534","DOI":"10.1021\/acs.jmedchem.0c00909","article-title":"Stepwise design of \u03b3-secretase modulators with an advanced profile by judicious coordinated structural replacements and an unconventional phenyl ring bioisostere","volume":"63","author":"Sarmiento","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0330","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1039\/D1MD00043H","article-title":"Phenyl bioisosteres in medicinal chemistry: discovery of novel \u03b3-secretase modulators as a potential treatment for Alzheimer's disease","volume":"12","author":"Ratni","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0335","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00044-023-03081-3","article-title":"Novel indanone-chalcone esters with potential anti-Alzheimer effects designed using hybridization and bioisosteric replacement approaches","volume":"32","author":"Azimian","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.109248_bb0340","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1021\/acschemneuro.3c00653","article-title":"Design, synthesis, and biological investigation of Quinazoline derivatives as multitargeting therapeutics in Alzheimer\u2019s disease therapy","volume":"15","author":"Verma","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116450","article-title":"Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer\u2019s disease treatment","volume":"271","author":"Verma","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0350","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1021\/acschemneuro.3c00245","article-title":"Design, synthesis, and biological evaluation of piperazine and N-benzylpiperidine hybrids of 5-phenyl-1, 3, 4-oxadiazol-2-thiol as potential multitargeted ligands for alzheimer\u2019s disease therapy","volume":"14","author":"Waiker","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2025.109248_bb0355","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1021\/acsomega.3c10276","article-title":"Structure-guided design, synthesis, and biological evaluation of peripheral anionic site selective and brain permeable novel oxadiazole-piperazine conjugates against Alzheimer\u2019s disease with antioxidant potential","volume":"9","author":"Singh","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.109248_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116511","article-title":"Structure-based design of multitargeting ChEs-MAO B inhibitors based on phenyl ring bioisosteres: AChE\/BChE selectivity switch and drug-like characterization","volume":"274","author":"La Spada","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115352","article-title":"Bioisosteric replacement based on 1, 2, 4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors","volume":"255","author":"Rullo","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0370","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.3390\/molecules26175208","article-title":"First-in-class isonipecotamide-based thrombin and cholinesterase dual inhibitors with potential for Alzheimer disease","volume":"26","author":"Purgatorio","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109248_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127240","article-title":"The development of a structurally distinct series of BACE1 inhibitors via the (Z)-fluoro-olefin amide bioisosteric replacement","volume":"30","author":"Frohn","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109248_bb0380","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.3390\/molecules28166032","article-title":"Scaffold morphing and in silico Design of Potential BACE-1 (\u03b2-secretase) inhibitors: a Hope for a newer Dawn in anti-Alzheimer therapeutics","volume":"28","author":"Bhatia","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109248_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106152","article-title":"Targeting neuronal calcium channels and GSK3\u03b2 for Alzheimer\u2019s disease with naturally-inspired Diels-Alder adducts","volume":"129","author":"Bisi","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0390","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.3390\/molecules28186579","article-title":"Recent development of novel Aminoethyl-substituted Chalcones as potential drug candidates for the treatment of Alzheimer\u2019s disease","volume":"28","author":"Sharma","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109248_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113565","article-title":"Design, synthesis, and biological evaluation of furosemide analogs as therapeutics for the proteopathy and immunopathy of Alzheimer\u2019s disease","volume":"222","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0400","doi-asserted-by":"crossref","first-page":"33247","DOI":"10.1039\/D4RA06330A","article-title":"Novel PPAR-\u03b3 agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis, in silico evaluation, PPAR-\u03b3 binding assay and transactivation and expression studies","volume":"14","author":"Priya","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109248_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114837","article-title":"Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer\u2019s disease agents","volume":"244","author":"Van Manh","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0410","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11030-019-09970-3","article-title":"5, 6-diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer\u2019s disease modifying agents","volume":"24","author":"Yazdani","year":"2020","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2025.109248_bb0415","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1039\/C8MD00545A","article-title":"Synthesis and receptor binding of thiophene bioisosteres of potent GluN2B ligands with a benzo [7] annulene-scaffold","volume":"10","author":"Baumeister","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2025.109248_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-020-00715-0","article-title":"Design and synthesis of multi-target directed 1, 2, 3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease","volume":"14","author":"Karimi Askarani","year":"2020","journal-title":"BMC Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0425","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.ejmech.2016.11.021","article-title":"Design, synthesis and SAR analysis of potent BACE1 inhibitors: possible lead drug candidates for Alzheimer\u2019s disease","volume":"125","author":"Tarazi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0430","doi-asserted-by":"crossref","first-page":"17602","DOI":"10.1039\/D0RA00663G","volume":"10","author":"Mishra","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109248_bb0435","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejmech.2014.07.021","article-title":"Tetrahydrobenzo [h][1, 6] naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting \u03b2-amyloid, tau, and cholinesterase pathologies","volume":"84","author":"Di Pietro","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109248_bb0440","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.bmcl.2019.03.050","article-title":"Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment","volume":"29","author":"Zhu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109248_bb0445","doi-asserted-by":"crossref","first-page":"1700163","DOI":"10.1002\/ardp.201700163","article-title":"Synthesis, molecular modeling, and evaluation of novel sulfonylhydrazones as acetylcholinesterase inhibitors for alzheimer\u2019s disease","volume":"350","author":"Fernandes","year":"2017","journal-title":"Arch. Pharm."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:31:04Z","timestamp":1765863064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825011289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":89,"alternative-id":["S0045206825011289"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109248","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in bioisosteric modifications for targeting Alzheimer's disease pathways","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109248"}}